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Abstract 
 
A 42-year-old Chinese man, known case of renal cell carcinoma with lung metastasis, was referred to Universiti 
Kebangsaan Malaysia Medical Centre for left eye blurring of vision for one month duration, which was worse upon 
waking up in the morning and cleared up after 1-2 hours. On examination, visual acuities were 6/6 in both eyes. No 
relative afferent pupillary defect. Left fundus showed inferonasal retinal detachment without macular involvement. 
No retina break, no retinitis and no choroidal lesion seen. Right eye examination was normal. Optical coherence 
tomography (OCT) of left eye showed subretinal fluid temporal and inferior to optic disc. Fundus fluorescein 
angiography (FFA) left eye showed hypofluoresence in early phase but hyperfluorescence with pin point leakage in 
late phase over inferonasal quadrant.  Indocyanine green (ICG) showed early hypofluoresence with late pin point 
hyperfluoresence in the same quadrant. A clinical diagnosis of exudative retinal detachment due to choroidal 
metastasis secondary to renal cell carcinoma was made. The patient was planned for cyber-knife radiotherapy of his 
left eye but unfortunately we lost the follow up. High index of suspicion and relevant investigation are needed for 
patients with visual complaints and history of renal cell carcinoma to diagnose choroidal metastasis. 
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Introduction 
 
The prevalence of uveal metastases from all forms of 
carcinoma is between 2.3% to 9.2% (1). The leading 
sites of primary cancer metastasis to uveal are breast 
(47%) and lung (21%), follow by gastrointestinal tract 
(4%), skin (2%), prostate (2%) and kidney (2%) (2). 
Renal cell carcinoma accounts for approximately 3% 
of adult malignancy (3) and frequently metastasizes 
via venous and lymphatic systems to lung, regional 
lymph nodes, liver, bone, and subcutaneous tissues. 
However, ocular metastasis from renal cell carcinoma 
have been reported to involve iris, ciliary body, 
choroids, eyelid, conjunctiva and lacrimal gland (4-7). 
In this paper, we describe a case of choroidal 
metastasis from renal cell carcinoma that presented 
with exudative retinal detachment and the 
characteristic features in angiography. 
 
Case Report 
 
A 42-year-old man presented with one month history 
of blurring of vision over the left eye which was worse 
after waking up in the morning and resolved after one 
to two hours. He was diagnosed to have stage 4 renal 
cell carcinoma with lung metastasis just one month 
prior to the onset of his ocular symptom. He was 
commenced on oral Pazopanib as the primary was 
deemed inoperable. A brain and orbital magnetic 
resonance imaging (MRI) had done at a private center 
prior and it reported possible metastasis to the brain 
and the left orbit.  
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Figure 1: (a) OCT of left macular revealed normal contour which explained the good vision of patient, (b) OCT of left optic disc 
revealed subretinal fluid (arrow) nasal and inferior to the disc with normal retinal pigmented epithelium and choroid. 
 
 
Figure 2: (a) and (b) FFA of left fundus in early phase showed hypofluorescence (arrow) in inferonasal quadrant and late phase 
pinpoint hyperfluorescence (arrow) in the same quadrant which was increasing in intensity, (c) and (d) ICG of left fundus showed 
early hypofluoresence (arrow) and late pinpoint hyperfluorescence (arrow) in the same quadrant. 
 
On examination, visual acuities were 6/6 in both eyes. 
The pupillary reactions were normal. Left eye 
conjunctiva vessels appeared dilated infero-nasally. 
Left fundus showed inferonasal retinal detachment 
without macular involvement. Shifting fluid was 
demonstrated. There was no retinal break, retinitis, 
choroiditis or mass seen. Right eye examination was 
unremarkable.  
 
Optical coherence tomography (OCT) analysis of the 
retinal layer revealed presence of subretinal fluid nasal 
and inferior to optic disc (Fig. 1a and 1b). Otherwise, 
there was no intraretinaloedema or thickening of 
retinal pigmented epithelium (RPE). Fundus 
fluorescein angiography (FFA) of left eye showed a 
lesion which was hypofluorescence in early phase but 
had diffuse pinpoint leakages in late phase at the 
inferonasal quadrant, underneath the retinal 
detachment (Fig. 2a and 2b). Indocyanine green (ICG) 
also showed early hypofluorescence with late pinpoint 
hyperfluorescence in the same quadrant (Fig. 2c and 
2d). These findings were commonly seen in choroidal 
metastatic tumour.  
 
A clinical diagnosis of exudative retinal detachment 
due to choroidal metastasis secondary to renal cell 
carcinoma was made. The patient was planned for 
cyber-knife radiotherapy of his left eye. However, he 
defaulted subsequent follow ups. 
 
Discussion 
 
Uvea is the vascular middle layer of the eye and is 
divided into iris, ciliary body and choroid. Choroid is a 
highly vascularized structure which supply nutrient 
and provides gas exchange for the outer part of the 
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retina.  In a survey of 950 uveal metastatic foci in 520 
eyes, choroid was the most common site of metastasis 
(88%) followed by the iris (9%), and the ciliary body 
(2%) (2). Choroid is highly vascularized and thus 
easily accessible by neoplastic cells which travel as 
emboli. For a tumour to metastasize from a distant site 
to the eye, the tumour emboli needs to pass through 
the internal carotid artery, ophthalmic artery, ciliary 
arteries and eventually the uveal tract to reach the 
choroidal layer (8). Choroidal metastasis is usually 
located at the posterior pole as tumour emboli is likely 
to reach the eye via short posterior ciliary arteries than 
through the longer and less numerous anterior vessels 
(8). Choroidal metastasis could be asymptomatic (2) if 
the lesion is small and located at the periphery. It 
usually becomes symptomatic when the lesion 
involves the macula and optic nerve or produce 
exudative retinal detachment involving the macular (9) 
as in our case. The hallmark for exudative retinal 
detachment is shifting fluid, which means that when 
the patient is lying down, the subretinal fluid 
accumulates in the macular area which contributes to 
the blurring of vision upon waking up. In upright 
position, the subretinal fluid will shift inferior to 
macular resulting in clearing up of the vision.  
 
Other ocular pathological conditions that may mimic 
choroidal metastasis are melanoma, lymphoma, 
choroidal haemangioma and choroidal osteoma. 
Investigations that aid in evaluation of these tumours 
include fluorescein angiography and indocyanine 
green angiography. Angiographic features for 
choroidal metastases are variable. The most commonly 
reported feature is hypofluorescence in the arterial and 
early venous phases in fluorescein angiography and 
becomes progressively hyperfluorescent with multiple 
pinpoint spotin the venous and late phases (9,10). 
Similar features were seen in our case. Other less 
common findings include normal fluorescence 
throughout the angiogram (9), hyperfluorescence in 
early phase which increases in late phase or early 
fluorescence in arteriovenous phase which further 
diminished in late phases (11). Pooling of dye occurs 
within the area of exudative retinal detachment in late 
phases (9,11). In our case, the fluorescein angiography 
revealed hypofluorescence in the early phase and 
pinpoint hyperfluorescence in the late phase within the 
area of exudative detachment (inferonasalquadrant). 
Neurosensory detachment together with localized area 
of metastatic tumour cells within the choroid 
surrounding the associated vasculature causing early 
hypofluorescence by blocking the light transmission. 
The pinpoint leakage seen in late phase was due to 
alteration in the overlying retinal pigment epithelium 
(12). It was postulated that abnormal vessels of 
tumours are more permeable and congested leading to 
change of oncotic and hydrostatic pressure resulting in 
neurosensory detachment (9). 
 
In a study of indocyanine green (ICG) 
videoangiographic findings in 5 cases of choroidal 
metastatic tumour, ICG is reported as a better modality 
in demonstrating the exact size of the tumour 
associated with serous retinal detachment as the 
infrared light can penetrate the detached retina and 
allow visualization of the choroidal lesion. Blocked 
fluorescent area seen in the early phase corresponded 
to the tumour. Late phase angiogram showed 
hyperfluorescence due to dye leakage through 
abnormal retinal pigment epithelium (12). Similar 
angiographic finding was noted in our patient. ICG in 
conjunction with fluorescein angiography are 
important in diagnosing and monitoring treatment 
response in cases of choroidal metastasis (12). 
 
Treatment for choroidal metastasis include systemic 
chemotherapy and/or hormonal therapy, radiotherapy 
(external beam, plaque brachytherapy, Gamma knife, 
cyber-knife, proton beam), transpupillary 
thermotherapy, laser photocoagulation/photodynamic 
therapy, intravitreal injection, cryotherapy, resection 
or enucleation (1,13). Evidence-based analysis favours 
radiotherapy for the sight-threatening uveal metastasis 
(1). Cyber-knife radiotherapy is offered to this patient 
as the system incorporated a newer noninvasive eye 
fixation monitoring system which obviates the need 
for muscle sutures, implanted radio-opaque markers 
and retrobulbar anesthesia. Cyber-knife delivers 
fractionated radiotherapy that causes less radiation 
damage to surrounding structures such as lens and 
ciliary body. 
 
The prognosis for choroidal metastasis is generally 
poor. The mean survival after onset of metastatic 
disease is 8 to 9 months (14). 
 
Conclusion 
 
Patient with renal cell carcinoma can present with 
exudative retinal detachment secondary to choroidal 
metastasis. This case highlights the angiographic 
features that can be seen inchoroidal metastasis. 
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